Advanced Code injection

Doriane Rey 10/27/26 Doriane Rey 10/27/26

Life Sciences Central expands its network after supporting 130+ additional Ontario life sciences companies in its first year

Arsheen Kaur 10/21/26 Arsheen Kaur 10/21/26

Deep Breathe Receives $1M Investment from FedDev Ontario

Arsheen Kaur 10/21/26 Arsheen Kaur 10/21/26

Genesys Capital Announces Second Close of Genesys University Seed Fund

Arsheen Kaur 10/21/26 Arsheen Kaur 10/21/26

Toronto Robotics Start-up Hopes to Expand Options for Surgical Procedures

Arsheen Kaur 10/20/26 Arsheen Kaur 10/20/26

OBIO® is a Proud Partner of MEDTEQ+ and envisAGE to Strengthen Innovation in Health & Aging Technology

Doriane Rey 10/14/26 Doriane Rey 10/14/26

Hôpital Montfort establishes an innovative partnership to accelerate Emergency Department care

Arsheen Kaur 10/6/26 Arsheen Kaur 10/6/26

Vasomune Therapeutics Completes Enrollment of Phase 2a Study of Pegevongitide (AV-001) in Patients Hospitalized with Pneumonia/ARDS

Arsheen Kaur 10/6/26 Arsheen Kaur 10/6/26

How AI Changes the Drug Discovery Equation

Doriane Rey 10/5/26 Doriane Rey 10/5/26

OBIO’s inaugural Early Adopter Health Network (EAHN®) Innovation Showcase

Arsheen Kaur 9/30/26 Arsheen Kaur 9/30/26

Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy

Arsheen Kaur 9/30/26 Arsheen Kaur 9/30/26

Government of Canada Invests in 10,000 AI-related Work Placements for Young Canadians

Doriane Rey 9/29/26 Doriane Rey 9/29/26

OBIO’s Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures

Arsheen Kaur 9/22/26 Arsheen Kaur 9/22/26

File your Accessibility Compliance Report (ACR) by December 31, 2026

Arsheen Kaur 9/22/26 Arsheen Kaur 9/22/26

Stem Cell Network makes First Direct Biotech Investment, Awarding $1 Million to Montreal-based RejuvenRx

Arsheen Kaur 9/22/26 Arsheen Kaur 9/22/26

QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly

Arsheen Kaur 9/22/26 Arsheen Kaur 9/22/26

Capital BioVentures Launches ASCENT26: Accelerating Canada’s Next Therapeutic Breakthroughs

Arsheen Kaur 9/22/26 Arsheen Kaur 9/22/26

Canada has Invested in Science. Now it Must Capture the Economic Benefits.

Arsheen Kaur 9/22/26 Arsheen Kaur 9/22/26

Biotech Sovereignty: Canada’s Next Strategic Imperative

Arsheen Kaur 9/9/26 Arsheen Kaur 9/9/26

RBC to Mobilize $1.4 billion to Back Canada's Next Global Technology Champions and Advance Nation-Building Efforts

Arsheen Kaur 9/8/26 Arsheen Kaur 9/8/26

AI-Fundamentals for the Bio-Economy